Toyota received 2,753 patents from the U.S. Patent and Trademark Office in 2021.
Detroit, Michigan (Jan. 21, 2022)
Compared to other automakers, Toyota received more patents from the USPTO in 2021, according to a yearly report by the Intellectual Property Owners Association (IPO). A total of 2,753 patents were awarded to Toyota’s engineers and scientists in 2021, including many in the field of battery research to support the electrification of vehicles as well as other categories like automated driving systems, hardware, software, artificial intelligence (AI), materials, and other inventions relating to mobility. Toyota has topped the list of automakers in this assessment for eight years running now.
Sandra Phillips-Rogers, general counsel, chief legal officer, and chief diversity officer for Toyota Motor North America, said: “We are pleased to be recognized as a global technology leader as indicated by the many patents given to Toyota.
Toyota’s extensive R&D efforts and the team members who bring these technologies to life are demonstrated by the number of issued patents.
According to Frederick Mau, intellectual property counsel and director of patent licensing for Toyota Motor North America, “this year’s patent list represents our efforts with respect to vehicle electrification, as evidenced by pioneering battery technology, as well as new IP to support Toyota’s transition into a mobility company.
Toyota has led the automotive industry for many years and continues to make significant research and development (R&D) investments. Since 2017, Toyota has spent more than $1 billion on research and development for robotics and driverless vehicles. The company invests more than $1 million every hour in cutting-edge technologies around the world.
In This Article...
Which automaker invests the most money in R&D?
According to a stock blog published on Wednesday, Tesla spends the most money per vehicle of any automaker on R&D. It’s simple enough to verify the data. The majority of auto manufacturers make their R&D budgets public.
How much does the auto industry invest in research and development?
The global R&D budget for the automotive industry is close to $100 billion.
$1,200 or $18 billion annually in the United States alone is spent on research & development for every vehicle. In actuality, the car sector funds 16% of all R&D expenditures globally across all businesses.
How much money do businesses invest in R&D?
A total of $493 billion was spent by businesses on R&D in 2019, of which $32 billion (7%) went toward basic research, $74 billion (15%) went toward applied research, and $387 billion (78%) went into development. The percentages (7 percent, 15 percent, and 79 percent, respectively) were identical to those in 2018. (table 1). Domestic R&D in the manufacturing sector, which is defined as R&D carried out in the 50 states and Washington, DC, totaled $286 billion (58%) in 2019. (table 2). The majority of the money comes from these businesses’ own resources (87 percent ). 87 percent of the $207 billion in domestic R&D undertaken by non-manufacturing industry enterprises was financed by their own resources, accounting for 42% of all domestic R&D.
In all industries, the U.S. federal government was a significant external funding source for R&D (also known as R&D paid for by others). The federal government contributed $22 billion of the $64 billion paid for by others, the majority ($15 billion) coming from the Department of Defense. (The complete set of data tables contains the accessible data.) Ninety one percent of federal financing went to the following industries: professional, scientific, and technological services (NAICS 54) ($6 billion), computer and electronic products (NAICS 334) ($6 billion), and aerospace products and parts ($8 billion). Other U.S. businesses ($21 billion) and overseas businesses, especially foreign parent corporations of U.S. subsidiaries ($20 billion), were significant sources of outside funding. This external nonfederal R&D funding was dispersed more widely across several industries (table 2). (For details on the availability of data tables with complete industry detail, see “Survey Information and Data Availability.)
Amounts spent on commercial R&D in the United States, broken down by the type of R&D, the source of the money, and the size of the business: 201719
What is R&D at Toyota?
Toyota R&D is committed to creating goods that appeal to people all around the world and are both cheap and of excellent quality. Toyota uses and safeguards the intellectual property that R&D produces as a key management resource to increase the value of the company.
What is the advertising budget for Toyota?
In 2020, Toyota, a Japanese automaker, spent $1.39 billion on advertising in American media. By spending the most on advertising that year, the corporation came in at number five, behind only General Motors and before Ford Motor.
What will Tesla’s R&D budget be in 2021?
Tesla’s history and projected growth rate for yearly and quarterly R&D costs from 2010 to 2022. Research and development costs are defined as costs associated with studies and the creation of new products.
- Tesla reported $0.865 billion in research and development costs for the three months ending March 31, 2022, a year over year rise of 29.88 percent.
- For the year ending March 31, 2022, Tesla spent $2.792B on R&D, a 52.32 percent increase from the previous year.
- Tesla spent $2.593B annually on R&D in 2021, up 73.91 percent from the previous year.
- Tesla spent $1.491 billion on research & development in 2020, an increase of 11.02 percent from 2019.
- Tesla’s yearly R&D costs fell by 8.01 percent to $1.343 billion in 2019, from $1.4 billion in 2018.
What much of money does Tesla invest in R&D?
LONDONAutomakers invest millions of dollars in public relations, marketing, and advertising. Not Tesla, though. The business invests much in research and development instead.
In contrast, Ford Motor Company spent $1,186 on R&D in 2020 as opposed to an average of $468 on advertising. General Motors spent $394 instead of $878, and Toyota Motor Corp. spent $454 instead of $1,063.
Which sectors invest the most in R&D?
In 2018, the top 1000 corporations invested $858 billion in research and development. The world’s R&D expenditures as a percentage of this sum are about 40%. Accordingly, $2 trillion or so was spent globally on research and development in 2018.
The business sector comes in at No. 1 in the list of top sources of R&D funding.
The corporate sector provides $267.3 billion in R&D funding, according to the most recent reports. That represents almost 63 percent of the total R&D output of the US. The federal government is the second-largest source. In the US, it contributes for $125.7 billion, or 30%, of R&D. Federal, academic, and commercial performers received grants from the fund, but several nonprofit organizations also benefited from it. About $15.1 billion, or 4%, came from non-profits to support R&D activities within their own companies. The academic sector spent $12.5 billion, or 3% of the R&D budget, on their own research. The municipal or state government contributed $3.8 billion, or 1%, to fund university research.
The US spent 2.8% of its GDP on R&D
Although it may top the list in terms of dollars spent, the US only dedicates 2.8 percent of its GDP to research and development.
The US leads R&D spending by countries, 2019
The newest statistics from Statista show that in 2018, the US spent 581 billion on research and development. According to UNESCO’s figures on international R&D expenditures,
- $496 billion was spent by China.
- $175.8 billion was spent by Japan.
- Germany’s outlay was $127.1 billion.
- In the Republic of Korea, $89.8 billion was spent.
- France made a $62.9 billion outlay.
US spent $194.2 billion on medical research spending
According to statistics on medical research expenditures by nation, the US spent $194.2 billion on medical and health R&D between 2017 and 2018. The sector allocated $66.7 billion of that to medical R&D. 22.2 percent was invested by federal agencies. Academic and research institutions made an 8.1 percent investment, followed by foundations with a 1.2 percent investment, state and local governments with a 1.1 percent investment, and non-profits with a 0.8 percent investment.
The pharmaceutical industry has the most R&D spending as a percentage of revenue globally.
The US, EU, Japan, China, and other nations’ data from 2,500 companies show that the pharmaceutical and biotechnology sector invests 15% of its revenue in R&D. R&D accounts for 10.6% of the software and computer services sector’s income. 8.4% of the income in the technology hardware and equipment sector is allocated to R&D. 5.9% of the income generated by the automotive and parts sector is allocated to R&D. Research and development accounts for 2.9% of the income of the chemical industry and 2.8% of the revenue of the aerospace and defense sector.
The average US R&D spending by industry of the S&P 100 is highest in the healthcare sector.
Health, at 16 percent, is the industry that spends the most on R&D, according to data culled from 57 of the 100 S&P 100 businesses. This is followed by industrial, energy, and materials at 3%, consumer staples at 3%, tech, media, and telecommunications at 13%, consumer discretionary at 11%, and consumer staples at 3%.
The top 5 technology companies collectively spent $76 billion.
The following can be used to determine how much money tech businesses spend on R&D. The top five technology corporations, according to the most recent data, invested $76 billion in R&D in 2018.
With $22.6 billion, or a 41 percent rise from the prior year, Amazon came out on top of the list.
Global pharma R&D spending surged by 3.9%.
Spending on pharmaceutical R&D increased to $165 billion globally in 2017, according to R&D reports. That represents an increase of 3.5%.
The top 20 pharmaceutical companies invested $97.2 billion in total, with Roche leading the pack with a $9.2 billion R&D spend. It’s interesting to note that R&D investment in the US has consistently outpaced that of other nations, including the UK.
AstraZeneca tops the list of the biggestR&D spenders in pharma with 25.63% of revenue spent on R&D.
Pharmaceutical businesses invested over 20% of their revenue in R&D activities in 2019. In June 2019:
- AstraZeneca invested 25.63%
- Eli Lilly invested 22.38%
- Roche invested 21.29 %
- Merck invested 19.70%
- Biogen invested 15.41%
Due to their lesser revenue, smaller businesses frequently end up spending a substantially larger percentageup to 50%on research and development.
Roche had an $11.06 billion R&D budget in 2018.
The top 15 big pharma companies invested more than $100 billion in medication R&D in 2018. The pharmaceutical firms with the highest R&D spending are:
- Roche, with a $11.06 billion budget
- Johnson & Johnson has a 10.8 billion dollar budget.
- Merck, with a $9.75 billion budget
- Novartis has a $9.07 billion budget.
- Pfizer has an approximate $8 billion budget.
- Sanofi has a $6.97 billion budget.
- Bristol-Myers Squibb has a $6.34 billion budget.
- Astra-Zeneca has a $5.93 billion budget.
- Eli Lilly has a $5.307 billion budget.
- GlaxoSmithKline has a $5.19 billion budget.
Tesla R&D spending in 2018 was $1.5 billion.
The firm that sells the most electric vehicles right now is Tesla. It has successfully cornered the premium car industry with its $1.5 billion in R&D expenditures in 2018. The amount is almost twice what it was in 2016. It is the top manufacturer of electric vehicles in the US as a result.
Amazon R&D spending was $28.8 billion.
With a staggering $28.8 billion invested in R&D in 2018, Amazon spent the most of their money in this area. Jeff Bezos, founder and CEO of Amazon, became the richest man in the world as a result of the investment’s success.
Alphabet R&D spending was $26 billion.
The most recent statistics show that Alphabet, the parent company of Google, invested $26.018 billion on R&D activities in 2019. This growth is amazing!
Apple R&D spending rose to $14.2 billion.
In 2018, Apple Inc. spent $14.2 billion on research and development. The sum is more than 15 years ago’s earnings for Apple and approximately 18 times what it spent in 2007, the year the iPhone was originally introduced.
Pfizer R&D spending is over $8 billion.
One of the biggest pharmaceutical corporations in the world, Pfizer, spent more than $8 billion on R&D in 2018. This is an improvement over prior years.
It represents a reduction from 2010, when the business invested $9.5 billion in R&D activities.
AI R&D spending is expected to increase to $97.9 billion.
Between the fiscal years 2018 and 2023, it is anticipated that R&D spending on artificial intelligence will increase from the current $37.5 billion to $97.9 billion, with a compound annual growth rate of 28.4%. Global finance will spend $5.6 billion, followed by the discrete manufacturing, healthcare, and process manufacturing sectors with investments totaling $5.9 billion.
The average SaaS companies R&D spending is 23%.
SaaS companies invested an average of 23% of their sales in research and development activities in 2018, according to R&D data. The median revenue for the most recent IPOs in 2018 and 2019 was $108 million, therefore the R&D expenditure was little over $30 million. These IPOs spent a little bit more, at 28 percent.
Most firms now spend more on R&D than advertising.
Up to the 1980s, businesses spent more than 15% of their entire income on advertising, according to data comparing R&D and advertising spending.
However, in recent years, the share of advertising spending has decreased to 0.8%. The proportion of R&D revenue to total business expenses has climbed from 1% to 7% throughout this time.
The majority of the businesses with greater R&D spending percentages were in the biotechnology or internet industries. Without much evidence of an increase in innovation initiatives, retail enterprises continue to spend 2 to 3 percent on advertising. In comparison, the manufacturing sector today invests 5% of its revenue in research and development.
The greatest notable change is seen in the technology sector, which spends over 10% more on R&D and less than 1% more on advertising.
Bottom Line
The only thing you need to do to determine a nation’s commitment to innovation and R&D is to look at how much of its GDP is spent on R&D activities. A nation’s prospects of prospering are increased by the number of businesses that are committed to innovation and research.